Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
Journal article published in 2018 by
Irati Zubizarreta,
Pablo Villoslada,
Raquel Cabezón,
Georgina Flórez-Grau 
,
Daniel Benitez-Ribas
,
Daniel Benitez-Ribas
This paper is made freely available by the publisher.
Full text: Download
Data provided by 